Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Scientists develop antibiotics against superbugs

Hong Kong scientists make major breakthrough in neutralizing drug-resistant superbugs.

Scientists in Hong Kong claim to have made a major medical breakthrough by developing a new family of antibiotics powerful enough to neutralize the superbugs that have spread worldwide and have been almost impossible to treat.

Bacteriologists at a university in Hong Kong claim they have developed a family of antibiotics powerful enough to neutralize multi-drug resistant superbugs, including methicillin-resistant Staphylococcus aureus, or MRSA.

MRSA refers to a group of genetically distinct bacteria pervasive in hospitals, nursing homes and even inside trains and buses in cities worldwide causing several difficult-to-treat infections.

There has been a decades-long global effort to fight MRSA and the search for new antibiotics to stem its spread has shown no progress since the superbugs’ emergence as early as the mid-1980s. People with open wounds or weakened immune systems are at greater risks of infection.

Bacterial drug resistance – public spaces and healthcare centers across the globe are now crawling with superbugs like MRSA – has been declared one of the biggest public health threats by World Health Organization Director-General Margaret Chan, who also served as Hong Kong’s public health chief.

In 2018, Hong Kong reported 1,218 cases of community-associated MRSA infections, a seven-fold jump compared with 2007, the year the first case was found in the city.

Researchers at the Hong Kong Polytechnic University (PolyU) said at a recent press conference that the novel small molecules they had just developed, based on new chemical structure and an antimicrobial mechanism, would be different from those of existing antibiotics incapable of sterilizing items with MRSA.

They claimed their new drug candidates demonstrated effective capabilities of inhibiting bacterial growth with no toxicity to human cells or tissues in numerous lab experiments.

The development and trial of the new class of antimicrobial agents, by PolyU’s Department of Applied Biology and Chemical Technology in partnership with the Chinese University of Hong Kong, is a potential breakthrough in the battle against MRSA.

“Our research is now at the end animal studies, conducting infectious model and pharmacokinetic observation and studies. These are the critical steps preceding clinical trials on humans for drug development,” said Dr Ma Cong, head of the research team.

“As a matter of fact, there are very few antibiotic-related studies among our peers abroad that are able to complete such a stage. Our findings so far are very promising … We believe further studies on these novel compounds will contribute to a new era of antibiotic discovery, contributing towards the fight against superbugs.”

Most antibiotics now in use function through disrupting the DNA synthesis or protein functions of harmful bacteria, while the new drug focuses on preventing the interaction between two proteins, NusB and NusE, which is crucial for synthesis of bacterial ribosomal ribonucleic acid and in turn bacterial cell proliferation.

The team developed a model based on the structure of the two proteins, and applied computer-aided screening to detect about 5,000 small molecule compounds with drug-like properties to act as inhibitors against protein interaction.

Some shortlisted compounds were then put to tests for antimicrobial effectiveness against different MRSA strains.

Test of the compounds on human lung and skin cells infected with MRSA indicated no significant toxicity. The fact that the two proteins exist only in bacteria and not in human cells has already addressed the toxicity concern, according to Dr Ma.

The research team has further structurally modified the compounds for optimization and named them “Nusbiarylins,” based on their target protein “NusB” and their “biaryl” structure.

Lab tests of Nusbiarylins against a panel of MRSA strains proved their consistent antibacterial effectiveness, much better than commonly used antibiotics including vancomycin, which is administered as the “last resort” antibiotic drug against superbugs in many Western countries.

Further pre-clinical studies on the in-vitro pharmacological properties of Nusbiarylins on human cells indicated that the compounds would not result in human blood cell breaking, an indication of being safe for injection, as well as excellent results in intestine absorption, meaning it is effective for oral taking.

The PolyU team won the “Global Innovation Award” at the TechConnect World Innovation Conference and Expo 2019 held in June in the United States.

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
House Republicans Move to Defund OECD Over Global Tax Dispute
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
Intel Reports Revenue Beats but Sees 81% Rise in Losses
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
CEO Resigns Amid Controversy Over Relationship with HR Executive
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
Tulsi Gabbard Unveils Evidence Alleging Political Manipulation of Intelligence During Trump Administration
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Trump Announces Coca-Cola to Shift to Cane Sugar in U.S. Production
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Air India Pilot’s Mental Health Records Under Scrutiny
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Moonshot AI Unveils Kimi K2: A New Open-Source AI Model
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Bitcoin Reaches New Milestone of $116,000
Severe Heatwave Claims 2,300 Lives Across Europe
Declining Beer Consumption Signals Cultural Shift in Germany
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
Western Europe Records Hottest June on Record
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
China’s Central Bank Consults European Peers on Low-Rate Strategies
France Requests Airlines to Cut Flights at Paris Airports Amid Planned Air Traffic Controller Strike
Poland Implements Border Checks Amid Growing Migration Tensions
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
×